Literature DB >> 32305141

Deep brain stimulation programming in Parkinson's disease: Introduction of current issues and perspectives.

M Aubignat1, M Lefranc2, M Tir3, P Krystkowiak3.   

Abstract

Deep brain stimulation (DBS) is a well-established treatment for Parkinson's disease (PD) leading to a significant reduction in motor and non-motor symptoms. Numerous factors contribute to positive outcomes for DBS including careful patient selection, lead placement and effective programming. Only DBS programming can be modified after patient implantation, therefore DBS programming plays a crucial role in improving clinical outcomes. In this paper, we review the literature to present current issues and perspectives for DBS programming in PD. Only a few algorithms proposed by experts for the initial programming and management of some adverse effects are available. No guidelines are available for programming sessions and medical treatment management during DBS follow-up. Moreover, emergence of increasingly complex lead designs makes programming more and more complex. Fortunately, in the last few years numerous techniques have emerged for optimization of DBS programming in PD.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Deep brain stimulation; Globus pallidus; Parkinson's disease; Programmation; Subthalamic nucleus

Mesh:

Year:  2020        PMID: 32305141     DOI: 10.1016/j.neurol.2020.02.009

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  3 in total

1.  A New Application of Functional Zonal Image Reconstruction in Programming for Parkinson's Disease Treated Using Subthalamic Nucleus-Deep Brain Stimulation.

Authors:  Jiaming Mei; Bowen Chang; Chi Xiong; Manli Jiang; Chaoshi Niu
Journal:  Front Neurol       Date:  2022-06-10       Impact factor: 4.086

2.  Basic Tips: How Do I Start Programming Deep Brain Stimulation in Parkinson Disease Patients?

Authors:  Carolina Gorodetsky; Alfonso Fasano
Journal:  Mov Disord Clin Pract       Date:  2021-04-06

3.  Dexmedetomidine Can Enhance PINK1/Parkin-Mediated Mitophagy in MPTP-Induced PD Mice Model by Activating AMPK.

Authors:  Cheng Chen; Yaohua Chen; Tingting Liu; Dan Song; Di Ma; Oumei Cheng
Journal:  Oxid Med Cell Longev       Date:  2022-04-12       Impact factor: 7.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.